Price movement over the last 24 hours
AFLAC Incorporated vs W W Grainger Inc — how do they compare? AFLAC Incorporated trades at $121.29 (market cap $61.84B), while W W Grainger Inc trades at $1,348.9 (market cap $64.04B). The key difference: AFLAC Incorporated and W W Grainger Inc are close in size by market cap, and AFLAC Incorporated pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AFL | GWW | |
|---|---|---|
Market Cap | $61.84B | $64.04B |
Sector | Financials | Technology |
52-Week High | $121.49 | $1.37K |
52-Week Low | $98.09 | $918.18 |
Enterprise Value | $70.50B | $66.13B |
Dividend Yield | 2.01% | 0.68% |
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
GWW trades at $1,370.16, up 2.02% today, showing strong momentum with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $11.65, beating estimates by 14%, and raised full-year guidance. Revenue growth remains solid at 10.1% year-over-year, with operating margins expanding 110 basis points to 16.7%. Recent news highlights Grainger's 25-year partnership with the American Red Cross and multiple analyst upgrades citing momentum potential.
The outlook remains positive with analyst consensus target of $1,260 suggesting modest upside. Strong profitability metrics (48.1% ROE, 19.66% ROA) support valuation, though elevated P/E of 36.84 warrants monitoring. Key risks include industrial sector cyclicality and margin pressure from rising costs. Institutional sentiment leans cautious with 63% hold ratings despite recent earnings beat.
Trailing returns across standard periods
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →